Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2026Sell(S)7K$82.21$557K1.1M
Jun 10, 2026Sell(S)8K$82.78$634K1.1M
Jun 10, 2026Sell(S)1K$84.18$91K1.1M
Jun 10, 2026Sell(S)2K$85.19$134K1.1M
Jun 10, 2026Sell(S)2K$86.27$199K1.1M
Jun 10, 2026Sell(S)614$86.89$53K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-073567) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML